comprehensive -WSS

comprehensive

author：explore 2025-10-03 00:04:12 - browse：459

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： A solution to the after

WSS

What will Novo Nordisk's VC do with its influx of cash?

CRISPR base editing slashes cholesterol levels in monkeys

R1 RCM gets $5.8 billion buyout offer from private equity firm

CRISPR base editing slashes cholesterol levels in monkeys

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Community Health Systems hospitals under DOJ investigation

focus

comprehensive

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

WHO recommends second malaria vaccine

Psychedelics group wrestles with new pharma identity

The biotech scorecard for Q4: 16 stock

Apple is now the first public company to be valued at $3 trillion

PBM reform efforts get punted in Congress

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Community Health Systems hospitals under DOJ investigation

Supreme Court strikes down use of affirmative action

New oral drug delivery patch is modeled after octopus tentacles

hotspot

The biotech scorecard for Q4: 16 stock

Will an HIV vaccine ever be a reality?

Stop Congress from blocking public access to science

RSV injection headlines need to be accurate for good uptake

Study points to new risk in gene therapy death of Terry Horgan

In utero gene editing: an explainer

entertainment

leisure time

Wikipedia

entertainment